Position in VTRS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$15,844,127
+$10,851,561 QoQ
Shares Held
997,741
+170.0% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#91
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $359,418,700 across 12 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,525,432 | $109,617,543 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
168,649 | $91,379,087 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
653,736 | $72,525,471 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
1,470,258 | $36,183,049 | |
| 5 | VTRS |
Viatris Inc
This page
|
997,741 | $15,844,127 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
367,355 | $12,445,987 | |
| 7 | ALKS |
Alkermes plc.
|
118,432 | $6,205,836 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
34,973 | $5,894,349 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,844,127 | 997,741 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $4,992,566 | 369,546 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,538,256 | 203,876 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,085,138 | 210,620 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,938,881 | 217,120 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $5,974,537 | 685,940 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $7,781,685 | 625,035 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $6,858,746 | 590,762 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $6,364,988 | 598,776 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $8,069,266 | 675,818 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,944,068 | 456,516 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,328,244 | 438,970 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $4,420,800 | 442,966 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,039,764 | 523,884 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $6,187,790 | 555,956 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $4,666,335 | 547,692 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $4,386,144 | 418,925 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $4,671,784 | 429,392 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,812,569 | 429,606 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,084,275 | 449,024 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $6,563,168 | 459,284 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $6,157,892 | 440,794 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $8,054,844 | 429,821 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||